The parent company, Kangtai Biological, has passed the EU QP audit, and its quality management system meets EU GMP standards.

Release date:

2022-05-09

Author:

Source:


Abstract

On May 6, 2022, the adenovirus‑vector COVID‑19 vaccine production facility of Shenzhen Kangtai Biological Products Co., Ltd., the parent company of Beijing Minhai Biotechnology Co., Ltd., located in Shenzhen, received a Certificate of Conformity issued by the European Union Qualified Person (QP). The EU QP audit focused on various aspects of Kangtai’s vaccine production line, including utility systems, the manufacturing management system, the quality assurance system, the warehousing and logistics system, as well as process and cleaning validation. Following the audit, a QP audit report was prepared to confirm compliance with EU standards, and a declaration of QP qualification was issued. This milestone marks that Kangtai’s adenovirus‑vector COVID‑19 vaccine is now ready for production.

On May 6, 2022, the adenovirus-vector COVID‑19 vaccine production facility of Shenzhen Kangtai Biological Products Co., Ltd., the parent company of Beijing Minhai Biotechnology Co., Ltd., located in Shenzhen, received a Certificate of Conformity issued by an EU Qualified Person (QP).

This EU QP audit focused on Kangtai Biological’s vaccine production line, examining its utility systems, manufacturing management system, QA system, warehousing and logistics system, as well as product process validation and cleaning validation. The audit culminated in the issuance of a QP audit report, confirming compliance with EU standards and providing a formal declaration of QP qualification.

This marks that Kangtai Biological’s adenovirus‑vector COVID‑19 vaccine production facility and quality management system have met EU GMP standards, ensuring the high‑quality development and commercial-scale manufacturing of the vaccine. It also represents a significant milestone in the company’s internationalization strategy, which will help further expand into overseas markets and support the global rollout of additional vaccine products.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09